SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

SC 13G - Viveon Health Acquisition Corp. (0001823857) (Subject)

SC 13G - Viveon Health Acquisition Corp. (0001823857) (Subject)

SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

SC 13G - Viveon Health Acquisition Corp. (0001823857) (Subject)

SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

SC 13G - Viveon Health Acquisition Corp. (0001823857) (Subject)

 The Company intends to make a request for the review of the delisting determination. At this time, the Securities have not been suspended and will continue to trade.

Viveon Health Acquisition Corp. (NYSE:VHAQ, VHAQW, VHAQR, VHAQU))))), a special purpose acquisition company (the "Company"), today announced that it will allow those holders of shares of the Company's common stock sold as part of the units issued in its initial public offering who elected to redeem their common stock ("Redeeming Stockholders") in connection with the special meeting of stockholders held today at 10:30 AM EST (the "Special Meeting"), to reverse their redemption requests by sending a DTC DWAC (Deposit/Withdrawal At Custodian) request to the Company's transfer agent, Continental Stock Transfer & Trust Company, by 5:00 PM EST on Friday, December 23, 2022. In connection with the

SAN DIEGO, Sept. 13, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative products to change the standard of care in patient treatments, today launched the 30 mL iteration of their Amplifine Platelet Rich Plasma (PRP) gel tubes, which will provide patients and practices with a larger volume of PRP to address varying areas of concern more efficiently. The 30 mL PRP tubes received a 510(k) clearance by the U.S. Food and Drug Administration (FDA) earlier this year. Suneva's Amplifine PRP gel tubes use a proprietary gel, designed to capture a high concentration of platelets in a short processing time, delivering cli

-SEC Filing

San Antonio, TX, May 02, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD), a healthcare services company focused on bringing innovative products and services to the senior care industry, would like to thank Jeffrey Coleman for his services as a Board Member to Clearday since its merger back in September 2021. James Walesa, CEO and Founder of Clearday, said, "Jeff has been a staunch supporter of the cause of innovating Senior Care for years. He has brought wisdom and experience to our Board over the last three (3) years. We know Jeff will be an asset to his next company. We wish him well in his new endeavors and feel confident that he will be met with great success." Clearday seeks

New York, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") re-affirms its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. The Company is focused on completing all of its regulatory filings to support completing the business combination with Clearday. Additionally, the Company will be appealing the recent decision by a hearings panel of the NYSE American's Committee for Review confirming the decision by the NYSE Staff to delist the Company's units, common stock and rights. As a result of that decisi

Viveon combination with Clearday continues to move forward New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQW, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") today is pleased to reconfirm its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. Clearday's mission is to bring digital companionship to the 170 million Americans turning 50 by 2030. The companies, together with their financial advisor, ClearThink Capital, have been working diligently on the transaction and look forward to continuing to work with ClearThink after the propose

Atlanta, GA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ, VHAQW, VHAQR, VHAQU the "Company"))) announces that, as previously disclosed in the Current Report on Form 8-K filed on December 26, 2023 with the United States Securities and Exchange Commission, the Company received a letter from the NYSE American LLC ("NYSE American" or the "Exchange") on December 22, 2023, stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company's Common Stock, Units and Rights (collectively, the "Securities") pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business

ATLANTA, GEORGIA, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) ("Viveon" or the "Company") announced today that, as previously disclosed in its annual report on Form 10-K for the fiscal year ended December 31, 2022, which was filed on August 24, 2023 with the U.S. Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company's ability to continue as a going concern. See further discussion in Note 1 to the Company's financial statements included

In Amendment to the Definitive Merger Agreement Clearday Receives Higher Valuation San Antonio, Texas, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Clearday, Inc. (OTCQX:CLRD), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, is pleased to announce an amendment to the Definitive Merger Agreement previously signed on April 5, 2023, issued by Viveon Healthcare Acquisition Corporation (NYSE:VHAQ) ("Viveon"). Viveon confirmed its commitment to the merger and increased Clearday's valuation. Viveon and Clearday continue to work to close the merger. James Walesa, CEO of Clearday, said, "Th

Norcross GA and San Antonio, TX, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon"), a special purpose acquisition company, and Clearday, Inc. (CLRD) ("Clearday"), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, announced today that they have amended the terms of their previously announced Merger Agreement, dated as of April 5, 2023 (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, a business combination between Viveon and Clearday will be effected through the merger of a wholly owned subsidiary of Viveon with and int

New York, April 25, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) (the "Company") announced today, that on April 18, 2023, the Company received a notice letter (the "Notice") from the NYSE Regulation Department (the "Staff") of the New York Stock Exchange American ("NYSE") notifying the Company that, based upon the Company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the "Annual Report"), it was not in compliance with the NYSE American's continued listing requirements. Pursuant to the Notice, the Company has six (6) months, to file its Annual Repor

CEO Jim Walesa will lead the combined company, Clearday, as Chief Executive OfficerJagi Gill, Chief Executive Officer and Chairman of Viveon Health, will join the Board of Directors of Clearday  San Antonio, Texas, April 12, 2023 (GLOBE NEWSWIRE) -- Clearday, Inc. (CLRD) ("Clearday" or the "Company"), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, announced that they have entered into a definitive merger agreement. Company Overview Clearday is transitio

CEO Jim Walesa will lead the combined company, Clearday, as Chief Executive Officer Jagi Gill, Chief Executive Officer and Chairman of Viveon Health, will join the Board of Directors of Clearday San Antonio, Tx and Norcross, GA, April 06, 2023 (GLOBE NEWSWIRE) -- Clearday, Inc. (CLRD) ("Clearday" or the "Company"), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, announced today that they have entered into a definitive merger agreement. Company Over